Acupoint transcutaneous electrical nerve stimulation in hospitalized COPD patients with severe dyspnoea: study protocol for a randomized controlled trial

Autor: Carles Fernández-Jané, Jordi Vilaró
Přispěvatelé: Universitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Randomized control trial
Acute exacerbation of chronic obstructive pulmonary disease
medicine.medical_specialty
Pulmons -- Malalties obstructives
Blinding
Neuroestimulació
Copd patients
Medicine (miscellaneous)
Acupuntura
Transcutaneous electrical nerve stimulation
Patient Readmission
AcuTENS
law.invention
03 medical and health sciences
Study Protocol
Pulmonary Disease
Chronic Obstructive
0302 clinical medicine
Randomized controlled trial
law
Dyspnoea
Acupuncture
Protocol
Medicine
616.2 - Patologia de l'aparell respiratori
COPD
Humans
Multicenter Studies as Topic
Pharmacology (medical)
Adverse effect
Aged
Randomized Controlled Trials as Topic
lcsh:R5-920
AECOPD
business.industry
Middle Aged
medicine.disease
030205 complementary & alternative medicine
Dispnea
Hospitalization
Dyspnea
030228 respiratory system
Spain
Emergency medicine
Transcutaneous Electric Nerve Stimulation
business
lcsh:Medicine (General)
Acupuncture Points
Zdroj: Trials
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
RECERCAT (Dipòsit de la Recerca de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
ISSN: 1745-6215
Popis: Background Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a major cause of hospital admissions and dyspnoea is its main symptom. Some studies have concluded that a new modality of acupuncture, called acupoint transcutaneous electrical nerve stimulation (acuTENS), could reduce dyspnoea in patients with COPD by increasing β-endorphin levels. However, those trials have been conducted mainly on patients in stable condition. This study aims to determine whether the administration of acuTENS can reduce dyspnoea in patients hospitalized for AECOPD. Methods A multicentre randomized control trial with blinding of participants and assessors will be conducted. A sample of 60 patients will be randomly assigned to receive 45 min of either real acuTENS or sham acuTENS treatment once a day for five consecutive days. The trial will be conducted at the “Hospital del Mar” in Barcelona (Spain) and the “Hospital Sant Joan de Déu de Manresa” in Manresa (Spain). The Borg scale at baseline and days 1 to 5 will be the primary outcome. Secondary outcomes will be the duration of the hospitalization, quantity of drugs administrated, expiratory peak flow adverse effects and mortality and readmissions at 3 months. Discussion AcuTENS is a non-pharmacological, non-invasive and inexpensive intervention. This trial will help to elucidate the potential role of acuTENS in the treatment of AECOPD. Trial registration ClinicalTrials.gov identifier: NCT02998957. Recruitment status: Recruiting. First posted: 21 December 2016. Last update posted: 2 October 2018. Trial registration dataset is available in Additional file 1. Protocol version 03. Issue date: 20 March 2018. Author: Carles Fernández.
Databáze: OpenAIRE
Externí odkaz: